Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial

Peer Review reports

Original Submission
13 Jul 2016	Submitted	Original manuscript
6 Nov 2016	Reviewed	Reviewer Report - Zheyu Wang
8 Nov 2016	Reviewed	Reviewer Report - Jiajun Wen
12 Jan 2017	Author responded	Author comments - Amy Cranston
Resubmission - Version 2
12 Jan 2017	Submitted	Manuscript version 2
Publishing
23 Jan 2017	Editorially accepted
7 Mar 2017	Article published	10.1186/s13063-017-1812-z

Back to article page